Facebook: World Allergy Organization
Twitter: World Allergy Organization
LinkedIn: World Allergy Organization
Instagram: World Allergy Organization
Back to Top

Immunomodulation - A Cure for Allergic Disease?


Carlos E. Baena-Cagnani
Ulrich Wahn


Carlos E. Baena-Cagnani

June 2004

Dear Colleagues,

As President of World Allergy Organization (WAO), I am pleased to welcome you to the 24th World Allergy Forum (WAF) Symposium: "Immunomodulation A Cure for Allergic Disease?" WAO strives to provide allergists with timely information about new treatments for allergic disease, about new indications for available therapies and to look towards future therapeutic developments. I thank our Member Society, the European Academy of Allergology and Clinical Immunology (EAACI), for hosting this symposium and enabling us to bring this educational program to you today in Amsterdam.

I am especially pleased to co-chair this session with Professor Ulrich Wahn, President of EAACI and a member of the World Allergy Forum Advisory Board. Professor Wahn and I will be working closely together over the coming year as WAO, EAACI and the German Society for Allergology and Clinical Immunology collaborate to bring you the World Allergy Congress in Munich , June 2005. Please mark June 26th - July 1st 2005 in your diary now this will be a Congress not to be missed!

WAO currently represents 70 allergy and clinical immunology societies around the globe. As membership rapidly increases, partnership with our members is the keystone of WAO's expanding global activities. Our educational programs, World Allergy Forum and Global Resources in Allergy (GLORIA), provide a forum for allergists to share clinical and scientific expertise in allergy. Our ESM (Emerging Societies Meeting) program works with countries in transition to foster the establishment of national allergy societies and provide guidelines for the local development of the specialty. WAO will publish A Revised Nomenclature for Allergy for Global Use, a global review based upon the EAACI Position Statement on Nomenclature of Allergy, in the May 2004 Journal of Allergy and Clinical Immunology. Later this year, our collaboration with World Health Organization will be published, Prevention of Allergy and Allergic Asthma.

These are just a few activities WAO facilitates on behalf of our members. As our activity base continues to expand, we hope you will find WAO becoming more and more relevant to your everyday practice.

Thank you for your participation in this WAO educational activity. WAO sincerely recognizes the unrestricted educational grant provided by Novartis to facilitate this event.

With my best regards,

Prof. Carlos E. Baena-Cagnani
President, World Allergy Organization
WAF Symposium Co-Chair


Ulrich Wahn

June 2004

Dear Colleagues,

Welcome to Amsterdam! On behalf of the European Academy of Allergology and Clinical Immunology, it is my pleasure to welcome my co-chair, World Allergy Organization President Professor Carlos Baena-Cagnani, to our Congress and welcome you all to this World Allergy Forum. During this symposium, three of the world's most renowned researchers will review the important question of whether immunomodulation strategies have the potential to provide a cure for allergic diseases.

Our first speaker, Jean Bousquet, will review allergen-specific immunotherapy. If administered at an early stage of allergic disease, can it alter the natural course of allergic asthma? Prevention of allergic disease is of course our ultimate goal. John Warner will review current knowledge on the prevention of IgE-sensitization in early life. Can prompt recognition of IgE-sensitization lead to management strategies that might prevent the consequent development and progression of allergic disease? In our last presentation, Stephen Wasserman will review the underlying principles of immunomodulation. This is an exciting and complex concept, but how likely is it that manipulation of the immune system and therapeutic entities now in development, either alone or in combination, will lead to a cure for allergic disease?

At the conclusion of this World Allergy Forum symposium, our objective is to:

  • describe our current understanding of the impact of immunotherapy on the natural course of allergic asthma
  • discuss strategies for the early-life prevention of IgE-sensitization and their impact on the consequent development and progression of allergic disease
  • review the principles of immunomodulation and the potential value of immunomodulatory therapies in allergic disease

We look forward to excellent presentations from three outstanding researchers in these areas.


Professor Ulrich Wahn
President, EAACI
WAF Symposium Co-Chair

Return to top
Return to WAF: Amsterdam index